148 related articles for article (PubMed ID: 15333859)
1. Survival and disease progression in UK patients with lymphangioleiomyomatosis.
Johnson SR; Whale CI; Hubbard RB; Lewis SA; Tattersfield AE
Thorax; 2004 Sep; 59(9):800-3. PubMed ID: 15333859
[TBL] [Abstract][Full Text] [Related]
2. Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry.
Oprescu N; McCormack FX; Byrnes S; Kinder BW
Lung; 2013 Feb; 191(1):35-42. PubMed ID: 23007140
[TBL] [Abstract][Full Text] [Related]
3. [Lung transplantation in sporadic lymphangioleiomyomatosis: study of 7 cases].
Ansótegui Barrera E; Mancheño Franch N; Peñalver Cuesta JC; Vera-Sempere F; Padilla Alarcón J
Med Clin (Barc); 2013 Oct; 141(8):349-52. PubMed ID: 23937818
[TBL] [Abstract][Full Text] [Related]
4. [Clinical analysis of pulmonary lymphangioleiomyomatosis].
Hu H; Wang W; Wang X
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(20):1256-60. PubMed ID: 11825531
[TBL] [Abstract][Full Text] [Related]
5. The vitamin D binding protein axis modifies disease severity in lymphangioleiomyomatosis.
Miller S; Coveney C; Johnson J; Farmaki AE; Gupta N; Tobin MD; Wain LV; McCormack FX; Boocock DJ; Johnson SR
Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30093573
[TBL] [Abstract][Full Text] [Related]
6. The NHLBI LAM Registry: Prognostic Physiologic and Radiologic Biomarkers Emerge From a 15-Year Prospective Longitudinal Analysis.
Gupta N; Lee HS; Ryu JH; Taveira-DaSilva AM; Beck GJ; Lee JC; McCarthy K; Finlay GA; Brown KK; Ruoss SJ; Avila NA; Moss J; McCormack FX;
Chest; 2019 Feb; 155(2):288-296. PubMed ID: 29940164
[TBL] [Abstract][Full Text] [Related]
7. Emerging clinical picture of lymphangioleiomyomatosis.
Cohen MM; Pollock-BarZiv S; Johnson SR
Thorax; 2005 Oct; 60(10):875-9. PubMed ID: 16055626
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of lymphangioleiomyomatosis in Japan: a nationwide cross-sectional study of presenting features and prognostic factors.
Hayashida M; Seyama K; Inoue Y; Fujimoto K; Kubo K;
Respirology; 2007 Jul; 12(4):523-30. PubMed ID: 17587419
[TBL] [Abstract][Full Text] [Related]
9. Clinical course and characterisation of lymphangioleiomyomatosis in a Brazilian reference centre.
Baldi BG; Freitas CS; Araujo MS; Dias OM; Pereira DA; Pimenta SP; Kairalla RA; Carvalho CR
Sarcoidosis Vasc Diffuse Lung Dis; 2014 Jul; 31(2):129-35. PubMed ID: 25078640
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis.
Khawar MU; Yazdani D; Zhu Z; Jandarov R; Dilling DF; Gupta N
J Heart Lung Transplant; 2019 Sep; 38(9):949-955. PubMed ID: 31303421
[TBL] [Abstract][Full Text] [Related]
11. The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis.
Kpodonu J; Massad MG; Chaer RA; Caines A; Evans A; Snow NJ; Geha AS
J Heart Lung Transplant; 2005 Sep; 24(9):1247-53. PubMed ID: 16143241
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Results of Bilateral Lung Transplantation in Patients With End-Stage Pulmonary Lymphangioleiomyomatosis.
Salman J; Ius F; Sommer W; Siemeni T; Fleissner F; Alhadidi H; Kugler C; Avsar M; Haverich A; Warnecke G; Tudorache I; Kuhn C
Prog Transplant; 2019 Jun; 29(2):115-121. PubMed ID: 31084354
[TBL] [Abstract][Full Text] [Related]
13. Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis.
Harknett EC; Chang WY; Byrnes S; Johnson J; Lazor R; Cohen MM; Gray B; Geiling S; Telford H; Tattersfield AE; Hubbard RB; Johnson SR
QJM; 2011 Nov; 104(11):971-9. PubMed ID: 21764810
[TBL] [Abstract][Full Text] [Related]
14. Lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in Japanese patients with tuberous sclerosis complex.
Tanaka M; Hirata H; Wataya-Kaneda M; Yoshida M; Katayama I
Respir Investig; 2016 Jan; 54(1):8-13. PubMed ID: 26718139
[TBL] [Abstract][Full Text] [Related]
15. Lymphangioleiomyomatosis--a brief review and estimation of excess risk.
Lee S
J Insur Med; 2012; 43(1):27-31. PubMed ID: 22397128
[TBL] [Abstract][Full Text] [Related]
16. Lung transplantation for lymphangioleiomyomatosis: the European experience.
Benden C; Rea F; Behr J; Corris PA; Reynaud-Gaubert M; Stern M; Speich R; Boehler A
J Heart Lung Transplant; 2009 Jan; 28(1):1-7. PubMed ID: 19134523
[TBL] [Abstract][Full Text] [Related]
17. Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis.
Ussavarungsi K; Hu X; Scott JP; Erasmus DB; Mallea JM; Alvarez F; Lee AS; Keller CA; Ryu JH; Burger CD
Respir Med; 2015 Oct; 109(10):1354-9. PubMed ID: 26321137
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy experiences among women with lymphangioleiomyomatosis.
Cohen MM; Freyer AM; Johnson SR
Respir Med; 2009 May; 103(5):766-72. PubMed ID: 19117742
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary lymphangioleiomyomatosis: a clinicopathological analysis of ten cases.
Ueng SH; Liu HP; Wu YC; Tsai YH; Lin HC; Lin MC; Lim KE; Huang SF
Chang Gung Med J; 2004 Mar; 27(3):201-9. PubMed ID: 15148998
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary lymphangioleiomyomatosis (LAM): examining oral contraceptive pills and the onset of disease.
Oberstein EM; Fleming LE; Gómez-Marin O; Glassberg MK
J Womens Health (Larchmt); 2003; 12(1):81-5. PubMed ID: 12639372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
